Table 2.
Education, awareness, counselling of about risk and benefits of available transplant options[11-23] |
Kidney exchange registry of incompatible pairs |
Dedicated transplant team to overcome logistic problems |
Uniform evaluation, care and follow-up |
Complete work up of pairs before allocation avoids chain collapse |
Standardization of HLA laboratory |
Robust Immunological evaluation prevents unequal outcome in pairs |
Non-anonymous allocation increases trust between pairs and transplant team |
Exchange kidney of similar quality |
Bonus for difficult to match and better HLA matched pairs |
Use of short (≤ 4-way exchange) vs long chain minimises logistic problems |
Simultaneous surgeries avoid risk of donor reneging |
Improve program using key features of other successful programs |
Legal, ethical, fair, transparent, equitable and patient centric policy by Competent Authorities |
HLA: Human leukocyte antigen.